Thursday, 13 June 2024 | 13:40 - 14:30
Plenary session
Format:In-person
18 participants
Talk 1: EATRIS: providing the right tools, at the right time, for vaccine development in a pandemic – David Morrow, EATRIS
Talk 2: A first-in-human study of a novel adjuvant for increased immunogenicity and dose-sparing of seasonal influenza vaccines – Bart Jacobs, Ghent University Hospital
2 speakers